katie sturino glp 1 GLP-1 Series #5: You asked, I answered GLP-1 Series #3: The Smug
Description
JAMA 2025;334:21862196
In this study, three tirzepatide doses has been giving (5 mg, 10 mg and 15 mg, subcutaneous injection, once a week), and a comparator, including placebo (two study by Fras [21, 22], SURPASS-1 [23], SURPASS-5 [24], SURMOUNT-1 [19], study by Heise [25], basal insulin [10 U/day insulin degludec (SURPASS3) [26], and 10 U/day insulin glargine (SURPASS-4) [27]], GLP-1 RAs [1mg semaglutide (SURPASS-2) [28], and 1.5mg dulaglutide [21], 0.75 mg dulaglutide (SURPASS Jmono) [29]]
J Pharm Sci (1973) 62:92630
If patients are looking at a $499-or-higher price tag, you might as well say it costs a million dollars a month, because theyre not going to access it. The ad features a New Yorker -styled comic strip, in which two employees at the Department of Health and Human Services (HHS) are holding a lengthy High-Priced Drug List. It would have been quicker to make a low-priced drug list, the punchline quips
The Precision Peptide Genetic Test analyzes variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313
Signal Transduction and Targeted Therapy, 7 (1), Article 272
